Access Bio Korea was established as a 100% subsidiary of Access Bio in the United States. Currently, rapid diagnostic kits are in the spotlight due to the global COVID-19 crisis, and we produce antibody/antigen identification diagnostic kits for COVID-19 as our main item. It also produces items from Wells Bio Co., Ltd., a subsidiary in Korea, and is sold worldwide in Asia, the Middle East, and Europe. In addition to products related to COVID-19, we produce Flu A&B and Dengue products as our main items. Our factory has acquired GMP and ISO and is constantly striving to improve productivity and quality.
View Top Employees from AccessBio Korea| Website | http://accessbio.net |
| Ticker | KOSDAQ:950130 |
| Revenue | $31 million |
| Employees | 4 (4 on RocketReach) |
| Founded | 2017 |
| Phone | (732) 873-4040 |
| Fax | (732) 873-4043 |
| Technologies |
JavaScript,
HTML,
PHP
+12 more
(view full list)
|
| Industry | Hospitals and Health Care, Manufacturing General, Biotechnology, Clinics/Outpatient Services, Manufacturing, Science and Engineering, Other Healthcare Services, Consulting, Medical Device, Health Care |
| SIC | SIC Code 384 Companies, SIC Code 38 Companies |
| NAICS | NAICS Code 334 Companies, NAICS Code 33 Companies |
Looking for a particular AccessBio Korea employee's phone or email?
AccessBio Korea Questions
The AccessBio Korea annual revenue was $31 million in 2024.
Young Kim is the Director of AccessBio Korea.
4 people are employed at AccessBio Korea.
The NAICS codes for AccessBio Korea are [334, 33].
The SIC codes for AccessBio Korea are [384, 38].
Top AccessBio Korea Employees
Related Companies
